Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Craig Atwood
University of Wisconsin Madison, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
GenRemedy, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Wisconsin Alzheimer's Disease Research center
PROJECT NARRATIVE - OVERALL The overarching scientific theme of the Wisconsin Alzheimer's Disease Research center (ADRC) is preclinical biomarkers of Alzheimer's disease (AD) and their role in predicting transition from preclincial to clincial stages of the disease. There is convincing evidence that AD pathology starts several decades before the onset of symptoms, and discovery of biomarkers that represent asymptomatic stages of the disease will lead to early diagnosis and effective treatments and prevention strategies for the disease. Identifying asymptomatic at risk individuals during preclinical stages of AD will allow initiation of therapies that will either slow or, preferably stop the progression of the disease. Research conducted at the Wisconsin ADRC has made seminal contributions to the field of AD research and has the potential to eventually find a cure for AD. This will have a great impact on patients and their families and will reduce the enormous societal costs associated with this devastating illness.
Filed on May 01, 2019.
Tell us what you know about Craig Atwood's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Craig Atwood”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Craig Atwood | University of Wisconsin Madison | Conflict of Interest | GenRemedy, LLC | $0 - $4,999 |
| Craig Atwood | University of Wisconsin Madison | Conflict of Interest | JangoBio, LLC | Value cannot be readily determined |
| Craig Atwood | University of Wisconsin Madison | Conflict of Interest | SoZo Pharma | Value cannot be readily determined |
| Craig Atwood | University of Wisconsin Madison | Conflict of Interest | JangoBio, LLC | >$600,000 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.